Technology status
The UNic™ yield multipliers are under evaluation by several industrial enzyme and biopharmaceutical companies in the USA and Europe. These companies have also obtained options to gain a commercial license.
In addition, ProteoNic has granted Research Licenses to several Universities and Institutes around the globe and has entered into collaborations with various biotech companies which are active in
a variety of applications.
A number of these partnerships have been disclosed. For further information, please go to our partner page.